UCTT

Current Thesis

UCTT is a second-order semicap-equipment play — small-cap leverage to LRCX/AMAT WFE spend with ~70% customer concentration. Narrative is STALLED into the binary window: LRCX prints 2026-04-23 AMC (2 days) and UCTT prints ~2026-04-29 to 2026-05-02 (8 days). Both reports are inside the operator earnings-blackout rule, so the play is not a fresh entry here — it's a post-print re-evaluation on either a guide-up follow-through breakout or a clean flush-and-reclaim. Structural thesis (2026 HBM capex cycle) still valid; tactical entry is not. DORMANT → DEFER until print reaction is on the tape.

Bull Case

• LRCX Q2 FY26 guide (reported 2026-01-29) pointed April-Q revenue to $5.0B ±$300M vs consensus $4.88B — UCTT bills LRCX 4–6 weeks ahead of LRCX shipments, so the current quarter was already loaded before 2026-04-21.
• HBM capacity expansion: SK Hynix announced 2026-03 plan to ~2x HBM3E output in 2026; etch/deposition tool demand is the exact UCTT-exposed bucket (via LRCX dielectric etch and AMAT PVD).
• Products GM recovery trajectory: FY2024 trough 15.8% → FY2025-Q4 (reported 2026-02-25) 17.4%. Street model baked in 18.0% for Q1 CY26; any beat to 18.5%+ re-rates the multiple.
• China/CXMT tailwind: UCTT Fluid Solutions (China) generated ~18% of FY25 revenue. SMIC's 2026-03-28 capex commentary flagged sustained domestic tool orders — direct read-through not yet in consensus.
• LRCX preannouncement absent: No negative preannouncement has hit the tape as of 2026-04-21 — in a cyclical turn, silence into print historically skews positive (LRCX has pre-warned 2x in the last 8 quarters when numbers were going to miss).

Bear Case

• Customer concentration is brutal: LRCX + AMAT = ~70% of revenue. LRCX 2025-Q3 guide-down (2025-07-30) cut UCTT revenue 22% sequentially with a 1-quarter lag. One LRCX miss on 2026-04-23 and the thesis is structurally broken in a 24-hour window.
• Services segment rolling over: -8% YoY in FY25-Q3, margin compressing 30% → 26%. Services drag alone can absorb the Products GM recovery.
• Samsung NAND deferral (Korean press 2026-03-12) removes a pillar of the DRAM-only bull case — memory capex remains lumpy, not secular.
• Balance sheet thin: Net debt ~$230M at Q4 FY25, interest coverage <3x. No cushion for a 2-quarter air-pocket — forced-seller dynamics possible if the cycle turns.
• Earnings blackout rule: per operator playbook, entering within 3 trading days of a binary print = gambling, not edge. UCTT is 6-8 trading days out as of 2026-04-21, and LRCX read-through is 2 days out. Time to add, not fresh-enter.

Setup & Price Structure

No live price feed this run. Structural levels to refresh once price context is restored: (1) 2025 high near $50 as the multi-quarter resistance shelf that must clear on post-earnings volume for the ACCELERATING leg to trigger; (2) 200-day MA as the trend filter — loss of 200d on >2x volume post-print = mechanical exit; (3) LRCX relative-strength line — UCTT historically trails LRCX by 2–4 weeks into cyclical turns, so if LRCX rips 2026-04-23 AMC and UCTT doesn't follow by 2026-04-28, the correlation is breaking and the thesis is compromised. Action is strictly gated on LRCX leading the tape first.

Catalyst Calendar (next 30 days)

• ~2026-04-23 AMC — LRCX earnings (April-Q). PRIMARY read-through. Guide-up historically pulls UCTT +6–10% next session; guide-down cuts 8–15%. This is the lead-tell for the UCTT print.
• ~2026-04-29 to 2026-05-02 — UCTT Q1 CY2026 earnings (FY26-Q1), est. AMC. Watch: (a) revenue >$560M (consensus anchor from LRCX guide), (b) Products GM ≥18.0%, (c) Q2 guide midpoint ≥$580M, (d) China commentary on domestic capex.
• ~2026-05-15 — AMAT earnings. Secondary read-through; matters more for confirmation than for initial trigger.
• No known product launches, contract announcements, or analyst days on the tape in the next 30d.

What Would Change Our Mind

• Upgrade to HIGH / trade-the-breakout: UCTT prints Q1 revenue >$570M AND guides Q2 ≥$590M AND Products GM ≥18.5% AND price clears $50 on >2x average volume — implies back-half acceleration and theme flips ACCELERATING. Size up post-print, not into it.
• Downgrade to AVOID / SKIP for the cycle: Any of (a) LRCX guides April-Q down >5% vs consensus on 2026-04-23, (b) UCTT Q1 Products GM <17% on the print (margin thesis broken), (c) price loses 200-day MA on >2x average volume post-earnings, (d) UCTT fails to follow LRCX by >5% within 3 sessions of a LRCX guide-up (correlation break = thesis broken).
• Stay DORMANT / DEFER: In-line LRCX print with no guide change, or UCTT prints in-line with flat guide — no edge, no trade. Re-evaluate on Q2 print.

Correlation Notes

Same-direction watchlist tickers (semicap beta): LRCX (primary customer, leading indicator — watch the 2026-04-23 print), AMAT (secondary customer, 2026-05-15 confirmation print), ACLS (small-cap semicap peer, similar beta), ICHR (direct UCTT competitor in fluid/gas delivery — moves near-1:1, DO NOT stack with UCTT; same business, same customers, same catalyst window). On the other side: memory-pure plays (MU, HYN) often front-run UCTT by 4–8 weeks — if MU has already ripped into the print, some of the upside is already pulled forward.

[recent archive — last 3 entries]

2026-04-21 — Dossier refreshed pre-earnings blackout

Source: regen_dossiers Prompt: watchlist_research_UCTT Status: DORMANT → DEFER (earnings window) Key update: LRCX (2026-04-23) and UCTT (~2026-04-29) both inside the 10-day binary window. No fresh entries until post-print reaction is on the tape.

2026-04-19 14:48 — Watchlist research refreshed (targeted)

Source: regen_dossiers Prompt: watchlist_research_UCTT News items: 1

2026-04-19 12:01 — Theme membership updated

Source: theme_discovery Previous themes: (none) New themes: ["semicap-equipment"] Strongest status: ACCELERATING